These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33811579)

  • 1. Pleiotropic, non-cell death-associated effects of inhibitors of receptor-interacting protein kinase 1 in the heart.
    Horvath C; Szobi A; Kindernay L; Ravingerova T; Adameova A
    Mol Cell Biochem; 2021 Aug; 476(8):3079-3087. PubMed ID: 33811579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection of ischaemic preconditioning is associated with inhibition of translocation of MLKL within the plasma membrane.
    Szobi A; Farkašová-Ledvényiová V; Lichý M; Muráriková M; Čarnická S; Ravingerová T; Adameová A
    J Cell Mol Med; 2018 Sep; 22(9):4183-4196. PubMed ID: 29921042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of necrostatin-1, an inhibitor of necroptosis, and its inactive analogue Nec-1i on basal cardiovascular function.
    Szobi A; Rajtik T; Adameova A
    Physiol Res; 2016 Nov; 65(5):861-865. PubMed ID: 27875900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
    Zhang L; Feng Q; Wang T
    Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation.
    Cho Y; McQuade T; Zhang H; Zhang J; Chan FK
    PLoS One; 2011; 6(8):e23209. PubMed ID: 21853090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrostatin: a potentially novel cardioprotective agent?
    Smith CC; Davidson SM; Lim SY; Simpkin JC; Hothersall JS; Yellon DM
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):227-33. PubMed ID: 17665295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1.
    Maki JL; Smith EE; Teng X; Ray SS; Cuny GD; Degterev A
    Anal Biochem; 2012 Aug; 427(2):164-74. PubMed ID: 22658960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart.
    Erdogmus Ozgen Z; Erdinc M; Kelle İ; Erdinc L; Nergiz Y
    Hum Exp Toxicol; 2022; 41():9603271211066066. PubMed ID: 35137609
    [No Abstract]   [Full Text] [Related]  

  • 10. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.
    Takahashi N; Duprez L; Grootjans S; Cauwels A; Nerinckx W; DuHadaway JB; Goossens V; Roelandt R; Van Hauwermeiren F; Libert C; Declercq W; Callewaert N; Prendergast GC; Degterev A; Yuan J; Vandenabeele P
    Cell Death Dis; 2012 Nov; 3(11):e437. PubMed ID: 23190609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage.
    Zhang Q; Wei S; Lu J; Fu W; Chen H; Huang Q; Chen Z; Zeng Z
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G551-G561. PubMed ID: 30735454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Receptor-Interacting Protein Kinase 1 with Necrostatin-1s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model.
    Wang Q; Zhou T; Liu Z; Ren J; Phan N; Gupta K; Stewart DM; Morgan S; Assa C; Kent KC; Liu B
    Sci Rep; 2017 Feb; 7():42159. PubMed ID: 28186202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
    Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
    Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrostatin-1 ameliorates adjuvant arthritis rat articular chondrocyte injury via inhibiting ASIC1a-mediated necroptosis.
    Chen Y; Zhu CJ; Zhu F; Dai BB; Song SJ; Wang ZQ; Feng YB; Ge JF; Zhou RP; Chen FH
    Biochem Biophys Res Commun; 2018 Oct; 504(4):843-850. PubMed ID: 30219231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.
    Sun W; Wu X; Gao H; Yu J; Zhao W; Lu JJ; Wang J; Du G; Chen X
    Free Radic Biol Med; 2017 Jul; 108():433-444. PubMed ID: 28414098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury.
    Yin B; Xu Y; Wei RL; He F; Luo BY; Wang JY
    Brain Res; 2015 Jun; 1609():63-71. PubMed ID: 25801119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1).
    Yu J; Zhong B; Zhao L; Hou Y; Wang X; Chen X
    Free Radic Biol Med; 2021 Sep; 173():64-69. PubMed ID: 34252539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of RIP1 using necrostatin-1 (Nec-1) ameliorated damage and inflammation of HBV X protein (HBx) in human normal hepatocytes.
    Xie L; Huang Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1194-1199. PubMed ID: 30963789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of regulated necrosis attenuates receptor-interacting protein kinase 1-mediated ischemia-reperfusion injury after lung transplantation.
    Kanou T; Ohsumi A; Kim H; Chen M; Bai X; Guan Z; Hwang D; Cypel M; Keshavjee S; Liu M
    J Heart Lung Transplant; 2018 Oct; 37(10):1261-1270. PubMed ID: 29907500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of RIP1 inhibition by necrostatins.
    Xie T; Peng W; Liu Y; Yan C; Maki J; Degterev A; Yuan J; Shi Y
    Structure; 2013 Mar; 21(3):493-9. PubMed ID: 23473668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.